McCaskill Opioid Investigation Expanding

United States Senator Claire McCaskill recently announced that she is expanding her wide-ranging investigation into the causes of the current opioid epidemic by requesting information and documents from four additional pharmaceutical manufacturers and three opioid distributors. Her requests focus on the distribution of opioids and the efforts leading companies have made to monitor, report, and investigate the diversion of drugs for illicit use. Drug diversion occurs when pharmaceutical products meant for legal use by individuals are transferred to others for illicit use, including through the black market.     McCaskill’s newest requests for documents and information from opioid manufacturers were sent to Mallinckrodt, Endo, Teva, and Allergan, while a prior request to McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc., focused on their distribution of opioid products. McCaskill has previously requested information related to sales and marketing materials, internal addiction studies, details on compliance with government settlements and donations to third party advocacy groups from major opioid manufacturers. Initial Requests McCaskill’s request to distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc., included requests for documents and information such as: Internal estimates received from outside vendors or consultants concerning the risk of diversion associated with opioid...
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs